stoxline Quote Chart Rank Option Currency Glossary
  
(ATMP)
  0 (0%)    01-19 18:50
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2026-01-16 4:46:26 PM
Short term     
Mid term     
Targets 6-month :  34.96 1-year :  40.84
Resists First :  29.94 Second :  34.96
Pivot price 29.01
Supports First :  28.9 Second :  28.26
MAs MA(5) :  29.53 MA(20) :  28.89
MA(100) :  28.53 MA(250) :  29.04
MACD MACD :  0.2 Signal :  0.1
%K %D K(14,3) :  89 D(3) :  89.5
RSI RSI(14): 67.6
52-week High :  32.09 Low :  25.65
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ ATMP ] has closed It is unclear right now based on current values. 61.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 29.97 - 30.09 30.09 - 30.2
Low: 29.42 - 29.57 29.57 - 29.69
Close: 29.64 - 29.89 29.89 - 30.09
Company Description

Headline News

Sun, 18 Jan 2026
ATMP SEC Filings - Barclays ETN+ Select MLP 10-K, 10-Q, 8-K Forms - Stock Titan

Sun, 11 Jan 2026
ATMP Facilities: The Cost of Manufacturing a Magic Bullet - CSRwire

Sun, 04 Jan 2026
Skanska, Flatiron Advance $445M LAX Roadway Package as ATMP Work Scales Up - Engineering News-Record

Tue, 02 Dec 2025
2025-12-02-ATMP-voluntary-agreement-comment-period - Golden Gate National Recreation Area (U.S - National Park Service (.gov)

Thu, 20 Nov 2025
Advanced Therapy Medicinal Products (ATMPs) - Association of the British Pharmaceutical Industry (ABPI)

Tue, 30 Sep 2025
CTGT/ATMP clinical trials surge in China, as first stem cell therapy product is conditionally authorized - www.hoganlovells.com

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android